Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Tselis

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Archives of Neurology|April 6, 1999
Multiple sclerosis: therapeutic updateA C Tselis, R P Lisak
Current Opinion in Neurology|June 1, 1995
Acute disseminated encephalomyelitis and isolated central nervous system demyelinative syndromesA C Tselis, R P Lisak
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2001
Spinal epidural lipomatosis in a human immunodeficiency virus-positive patient receiving steroids and protease inhibitor therapyJ R Ebright, M A Stellini, A C Tselis
Annals of Internal Medicine|October 1, 1996
Cytomegalovirus encephalitisJ R Arribas, G A Storch, D B Clifford, et al.
Neurology|January 29, 2003
Intercaudate nucleus ratio as a linear measure of brain atrophy in multiple sclerosisC Caon, M Zvartau-Hind, W Ching, et al.
European Journal of Neurology|April 4, 2001
A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosisO A Khan, A C Tselis, J A Kamholz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 25, 2002
A prospective, open-label treatment trial to compare the effect of IFNbeta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing--remitting multiple sclerosis: results after 18 months of therapyO A Khan, A C Tselis, J A Kamholz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 28, 2001
Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapyO A Khan, M Zvartau-Hind, C Caon, et al.
Neurology|February 20, 1999
HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathyD B Clifford, C Yiannoutsos, M Glicksman, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Archives of Neurology|April 6, 1999
Multiple sclerosis: therapeutic updateA C Tselis, R P Lisak
Current Opinion in Neurology|June 1, 1995
Acute disseminated encephalomyelitis and isolated central nervous system demyelinative syndromesA C Tselis, R P Lisak
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2001
Spinal epidural lipomatosis in a human immunodeficiency virus-positive patient receiving steroids and protease inhibitor therapyJ R Ebright, M A Stellini, A C Tselis
Annals of Internal Medicine|October 1, 1996
Cytomegalovirus encephalitisJ R Arribas, G A Storch, D B Clifford, et al.
Neurology|January 29, 2003
Intercaudate nucleus ratio as a linear measure of brain atrophy in multiple sclerosisC Caon, M Zvartau-Hind, W Ching, et al.
European Journal of Neurology|April 4, 2001
A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosisO A Khan, A C Tselis, J A Kamholz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 25, 2002
A prospective, open-label treatment trial to compare the effect of IFNbeta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing--remitting multiple sclerosis: results after 18 months of therapyO A Khan, A C Tselis, J A Kamholz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 28, 2001
Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapyO A Khan, M Zvartau-Hind, C Caon, et al.
Neurology|February 20, 1999
HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathyD B Clifford, C Yiannoutsos, M Glicksman, et al.
Pageof 1